Forward Look

To reduce your long-term cancer risk, make sure the tests are justified.

by Ingfei Chen

Forward Look

An experimental treatment shows the potential of a new family of targeted drugs.

by Stephen Ornes

Forward Look

Sigmoidoscopy may be a good option for colorectal cancer screening.

by Sue Rochman

Forward Look

Q&A with Elizabeth Blackburn, professor of biochemistry and physiology at the University of California, San Francisco.

by Rabiya Tuma

Forward Look

Evidence of colorectal screening benefit mounts.

by Sue Rochman

Forward Look

A link between the popular remedy and cancer prevention needs to be borne out in clinical trials.

by Stephen Ornes

Forward Look

Lab results spur researchers to test low-cost medication on humans.

by Stephen Ornes

Forward Look

Some states are mandating that doctors tell patients about breast density, which can affect cancer risk.

by Mitzi Baker

Accurate reporting of family histories could be key to risk reduction.

by Mitzi Baker

In the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?

by Charlotte Huff